Vedere Bio, Inc.

The first thing that comes to mind when thinking about gene therapy is its ability to replace a missing gene or correct a defective one. A gene therapy vector can also be used to insert instructions f

A week after announcing a share buyback worth up to $15bn, Novartis AG has dipped into its cash pile for a spot of M&A to acquire Gyroscope Therapeutics Limited and the UK biotech's one-time gene

Almost a year after acquiring optogenetics specialist Vedere Bio, Inc. , Novartis AG has decided to buy another in the shape of Swiss inherited eye disease expert Arctos Medical . Arctos is a Uni

Private biopharmaceutical companies raised more than $1bn from venture capital, seed financing and government investments during the past week, including Eliem Therapeutics, Inc. , which said on 24 M